Organoid bioprinting

At Polbionica, we develop bioprinted organoids and 3D tissue models that accurately replicate physiological conditions, including tumor microenvironments. These advanced models enable more effective drug testing, toxicity assessment, and a reduction in animal usage in line with the 3Rs principle.

We offer:

• pancreatic islet models (organ-on-a-chip),
• liver and hepatocellular carcinoma organoids
• endothelial vascular models with sustained flow.

Our solutions support drug toxicity testing, screening of novel compounds, metastasis studies, and research into liquid biopsy techniques.